Synthetic therapeutic peptides: science and market
- PMID: 19879957
- DOI: 10.1016/j.drudis.2009.10.009
Synthetic therapeutic peptides: science and market
Abstract
The decreasing number of approved drugs produced by the pharmaceutical industry, which has been accompanied by increasing expenses for R&D, demands alternative approaches to increase pharmaceutical R&D productivity. This situation has contributed to a revival of interest in peptides as potential drug candidates. New synthetic strategies for limiting metabolism and alternative routes of administration have emerged in recent years and resulted in a large number of peptide-based drugs that are now being marketed. This review reports on the unexpected and considerable number of peptides that are currently available as drugs and the chemical strategies that were used to bring them into the market. As demonstrated here, peptide-based drug discovery could be a serious option for addressing new therapeutic challenges.
Copyright 2009 Elsevier Ltd. All rights reserved.
Similar articles
-
Trends in risks associated with new drug development: success rates for investigational drugs.Clin Pharmacol Ther. 2010 Mar;87(3):272-7. doi: 10.1038/clpt.2009.295. Epub 2010 Feb 3. Clin Pharmacol Ther. 2010. PMID: 20130567 Review.
-
[The discovery process in the pharmaceutical industry].J Soc Biol. 2009;203(3):249-69. doi: 10.1051/jbio:2009030. Epub 2009 Oct 16. J Soc Biol. 2009. PMID: 19833071 Review. French.
-
Learning lessons from drugs that have recently entered the market.Drug Discov Today. 2011 May;16(9-10):398-411. doi: 10.1016/j.drudis.2011.03.003. Epub 2011 Mar 23. Drug Discov Today. 2011. PMID: 21414418 Review.
-
Strategies for bringing drug delivery tools into discovery.Int J Pharm. 2011 Jun 30;412(1-2):1-7. doi: 10.1016/j.ijpharm.2011.03.024. Epub 2011 Mar 21. Int J Pharm. 2011. PMID: 21421040 Review.
-
The value of drug repositioning in the current pharmaceutical market.Drug News Perspect. 2009 Mar;22(2):119-25. doi: 10.1358/dnp.2009.22.2.1303818. Drug News Perspect. 2009. PMID: 19330170 Review.
Cited by
-
Protease-resistant peptide design-empowering nature's fragile warriors against HIV.Biopolymers. 2012;98(5):431-42. doi: 10.1002/bip.22073. Biopolymers. 2012. PMID: 23203688 Free PMC article. Review.
-
Recent Progress of Multifunctional Molecular Probes for Triple-Negative Breast Cancer Theranostics.Pharmaceutics. 2024 Jun 14;16(6):803. doi: 10.3390/pharmaceutics16060803. Pharmaceutics. 2024. PMID: 38931924 Free PMC article. Review.
-
Design and Synthesis of Novel Triazole-based Peptide Analogues as Anticancer Agents.Iran J Pharm Res. 2019 Summer;18(3):1299-1308. doi: 10.22037/ijpr.2019.111722.13320. Iran J Pharm Res. 2019. PMID: 32641940 Free PMC article.
-
Molecular logistics using cytocleavable polyrotaxanes for the reactivation of enzymes delivered in living cells.Sci Rep. 2013;3:2252. doi: 10.1038/srep02252. Sci Rep. 2013. PMID: 23872688 Free PMC article.
-
Depot-Based Delivery Systems for Pro-Angiogenic Peptides: A Review.Front Bioeng Biotechnol. 2015 Jul 16;3:102. doi: 10.3389/fbioe.2015.00102. eCollection 2015. Front Bioeng Biotechnol. 2015. PMID: 26236708 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials